Other
Total Joint Arthroplasty
21
Pipeline Programs↗
3
Active Trials↗
13
Companies Involved↗
Total Joint Arthroplasty is an emerging landscape with 21 programs across 13 companies. The most active players are Viatris Specialty LLC, Neurim Pharmaceuticals Ltd., Hikma Pharmaceuticals LLC. 6 therapies are approved with 3 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical3
Phase 18
Phase 21
Phase 33
Analysis
Trial Status
24
clinical trials
Completed12 · 50%
Withdrawn6 · 25%
Unknown status2 · 8%
Recruiting1 · 4%
Active, not recruiting1 · 4%
Not yet recruiting1 · 4%
Other1 · 4%
Clinical Trials
Trial Activity
24 trials
Total Joint Arthroplasty and Sleep
Completed·—·Phase 4·NCT03968939·55 enrolled
Tranexamic Acid Dosing for Total Joint Arthroplasty
Completed·—·Phase 4·NCT02584725·84 enrolled
Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty
Completed·—·Phase 1·NCT04437888·200 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)